ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 239 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $292,000 | -28.6% | 7,231 | +1.7% | 0.04% | -26.3% |
| Q2 2015 | $409,000 | -15.7% | 7,110 | -6.6% | 0.06% | -14.9% |
| Q1 2015 | $485,000 | +3.6% | 7,610 | +0.3% | 0.07% | -2.9% |
| Q4 2014 | $468,000 | +437.9% | 7,584 | +275.4% | 0.07% | +475.0% |
| Q1 2014 | $87,000 | -73.4% | 2,020 | -75.4% | 0.01% | -77.8% |
| Q4 2013 | $327,000 | +22.0% | 8,202 | +15.1% | 0.05% | +25.6% |
| Q3 2013 | $268,000 | -33.5% | 7,126 | -52.5% | 0.04% | -50.0% |
| Q2 2013 | $403,000 | +18.9% | 15,000 | -25.0% | 0.09% | +36.5% |
| Q1 2013 | $339,000 | – | 20,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |